Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan to Improve Modulator Response in Cystic Fibrosis
NCT06364176Phase 2Recruiting
- Sponsor
- University of Kansas Medical Center
- Start
- Jun 2024
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of losartan in cystic fibrosis (CF), sponsored by University of Kansas Medical Center. Started Jun 2024; status: recruiting.
02
Drugs
losartan
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT06364176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06364176.